U.S. Cetirizine Dihydrochloride Prices to Decline by End of Q3 on Trade Exemptions and Stockpiling

Key Highlights

• President Trump’s *** tariffs on India took effect on August **, but pharmaceuticals were exempted.
• Indian pharmaceutical exporters remain critical, supplying nearly *** of U.S. generic drug demand.
• U.S. buyers pre-stocked medicines anticipating tariffs, ensuring sufficient Cetirizine Dihydrochloride supply currently.
• Trump urged ** drugmakers to lower U.S. drug prices by September **, including offering Medicaid patients the lowest prices available in developed countries.
• Earlier threats of up to **** tariffs on pharmaceutical imports raised concerns about price hikes and shortages.
• Transitioning API and drug production away from India would take *–* years, underscoring current supply chain reliance.

At the demand side, certain U.S. purchasers hoarded prior to tariffs taking effect, easing short-term pressure on prices of Cetirizine Dihydrochloride. The exception of the pharmaceutical tariff permitted uninterrupted flow from India, avoiding abrupt cost escalation of Cetirizine Dihydrochloride. Concurrently, President Trump&#**;s request to drug companies to lower prices by the...